281 related articles for article (PubMed ID: 33330440)
1. Implantable and Injectable Biomaterial Scaffolds for Cancer Immunotherapy.
Li J; Luo Y; Li B; Xia Y; Wang H; Fu C
Front Bioeng Biotechnol; 2020; 8():612950. PubMed ID: 33330440
[TBL] [Abstract][Full Text] [Related]
2. Advances in immunotherapy delivery from implantable and injectable biomaterials.
Leach DG; Young S; Hartgerink JD
Acta Biomater; 2019 Apr; 88():15-31. PubMed ID: 30771535
[TBL] [Abstract][Full Text] [Related]
3. Delivery strategies of cancer immunotherapy: recent advances and future perspectives.
Zhao Z; Zheng L; Chen W; Weng W; Song J; Ji J
J Hematol Oncol; 2019 Nov; 12(1):126. PubMed ID: 31779642
[TBL] [Abstract][Full Text] [Related]
4. Cancer Immunotherapy and Delivery System: An Update.
Yang M; Olaoba OT; Zhang C; Kimchi ET; Staveley-O'Carroll KF; Li G
Pharmaceutics; 2022 Aug; 14(8):. PubMed ID: 36015256
[TBL] [Abstract][Full Text] [Related]
5. Localized delivery of immunotherapy via implantable scaffolds for breast cancer treatment.
Hope A; Wade SJ; Aghmesheh M; Vine KL
J Control Release; 2022 Jan; 341():399-413. PubMed ID: 34863842
[TBL] [Abstract][Full Text] [Related]
6. Hydrogel-By-Design: Smart Delivery System for Cancer Immunotherapy.
Cui R; Wu Q; Wang J; Zheng X; Ou R; Xu Y; Qu S; Li D
Front Bioeng Biotechnol; 2021; 9():723490. PubMed ID: 34368109
[TBL] [Abstract][Full Text] [Related]
7. Three-dimensional (3D) scaffolds as powerful weapons for tumor immunotherapy.
Han S; Wu J
Bioact Mater; 2022 Nov; 17():300-319. PubMed ID: 35386452
[TBL] [Abstract][Full Text] [Related]
8. Immunoengineering with biomaterials for enhanced cancer immunotherapy.
Xie YQ; Wei L; Tang L
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2018 Jul; 10(4):e1506. PubMed ID: 29333729
[TBL] [Abstract][Full Text] [Related]
9. Surgery-free injectable macroscale biomaterials for local cancer immunotherapy.
Lei K; Tang L
Biomater Sci; 2019 Feb; 7(3):733-749. PubMed ID: 30637428
[TBL] [Abstract][Full Text] [Related]
10. Biomaterial-Based Sustained-Release Drug Formulations for Localized Cancer Immunotherapy.
Mujahid K; Rana I; Suliman IH; Li Z; Wu J; He H; Nam J
ACS Appl Bio Mater; 2023 Dec; ():. PubMed ID: 38050811
[TBL] [Abstract][Full Text] [Related]
11. Recent Biomaterial-Assisted Approaches for Immunotherapeutic Inhibition of Cancer Recurrence.
Mozafari N; Jahanbekam S; Ashrafi H; Shahbazi MA; Azadi A
ACS Biomater Sci Eng; 2024 Mar; 10(3):1207-1234. PubMed ID: 38416058
[TBL] [Abstract][Full Text] [Related]
12. Advanced Biomaterials for Cell-Specific Modulation and Restore of Cancer Immunotherapy.
Ruan S; Huang Y; He M; Gao H
Adv Sci (Weinh); 2022 May; 9(16):e2200027. PubMed ID: 35343112
[TBL] [Abstract][Full Text] [Related]
13. Engineered biomaterials for cancer immunotherapy.
Cai L; Xu J; Yang Z; Tong R; Dong Z; Wang C; Leong KW
MedComm (2020); 2020 Jun; 1(1):35-46. PubMed ID: 34766108
[TBL] [Abstract][Full Text] [Related]
14. Biomaterial-Based Implantable Devices for Cancer Therapy.
Chew SA; Danti S
Adv Healthc Mater; 2017 Jan; 6(2):. PubMed ID: 27886461
[TBL] [Abstract][Full Text] [Related]
15. Advancing immunotherapy using biomaterials to control tissue, cellular, and molecular level immune signaling in skin.
Shah SA; Oakes RS; Jewell CM
Adv Drug Deliv Rev; 2024 Jun; 209():115315. PubMed ID: 38670230
[TBL] [Abstract][Full Text] [Related]
16. Emerging biomaterials for tumor immunotherapy.
Xiao M; Tang Q; Zeng S; Yang Q; Yang X; Tong X; Zhu G; Lei L; Li S
Biomater Res; 2023 May; 27(1):47. PubMed ID: 37194085
[TBL] [Abstract][Full Text] [Related]
17. Improving the clinical impact of biomaterials in cancer immunotherapy.
Gammon JM; Dold NM; Jewell CM
Oncotarget; 2016 Mar; 7(13):15421-43. PubMed ID: 26871948
[TBL] [Abstract][Full Text] [Related]
18. Injectable Hydrogel-Based Combination Cancer Immunotherapy for Overcoming Localized Therapeutic Efficacy.
Kim J; Choi Y; Kim DH; Yoon HY; Kim K
Pharmaceutics; 2022 Sep; 14(9):. PubMed ID: 36145656
[TBL] [Abstract][Full Text] [Related]
19. Locally Injectable Hydrogels for Tumor Immunotherapy.
Zhang X; Guo X; Wu Y; Gao J
Gels; 2021 Nov; 7(4):. PubMed ID: 34842684
[TBL] [Abstract][Full Text] [Related]
20. Biomaterial scaffold-based local drug delivery systems for cancer immunotherapy.
Yang C; Blum NT; Lin J; Qu J; Huang P
Sci Bull (Beijing); 2020 Sep; 65(17):1489-1504. PubMed ID: 36747406
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
